An insider's perspective: defense of the pharmaceutical industry's marketing practices
- PMID: 23577377
An insider's perspective: defense of the pharmaceutical industry's marketing practices
Similar articles
-
Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.Albany Law Rev. 2009 Sep;73(1):243-82. Albany Law Rev. 2009. PMID: 20235401 No abstract available.
-
Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?JAMA. 2012 Feb 22;307(8):787-8. doi: 10.1001/jama.2012.182. JAMA. 2012. PMID: 22357827 No abstract available.
-
Pharmaceuticals and medical devices: FDA oversight.Issue Brief Health Policy Track Serv. 2013 Dec 30:1-123. Issue Brief Health Policy Track Serv. 2013. PMID: 24482893 No abstract available.
-
The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.J Surg Res. 2007 Jun 1;140(1):1-5. doi: 10.1016/j.jss.2006.10.010. J Surg Res. 2007. PMID: 17481979 Review.
-
Direct-to-consumer prescription drug advertising: trends, impact, and implications.Health Aff (Millwood). 2000 Mar-Apr;19(2):110-28. doi: 10.1377/hlthaff.19.2.110. Health Aff (Millwood). 2000. PMID: 10718026 Review.
Cited by
-
Physician Response to Contextualized Price-Comparison Claims in Prescription Drug Advertising.J Commun Healthc. 2017;10(3):195-204. doi: 10.1080/17538068.2017.1365999. Epub 2017 Aug 17. J Commun Healthc. 2017. PMID: 36570040 Free PMC article.